Venous oxygen saturation has been traditionally used as a marker for tissue hypoxia. A wide range of factors can affect it. Literature abounds with articles on the use of the same in decision making and clinical management of patients in shock. Likewise, the application of venous saturation in patients undergoing cardiac and noncardiac surgery has been demonstrated. The controversy as to whether superior vena cava oxygen saturation can replace the traditional mixed venous oxygen saturation is never ending. Irrespective of the body of evidence, it is recommended that clinical decision should not be based on a single value, and a range of values needs to be incorporated to differentiate a critically ill from a noncritically ill patient.
Introduction
Morbidity and mortality after major cardiac surgeries are serious issues to any health care system. 1 Even for the patients who leave the hospital, postoperative complications are an important determinant of long-term survival. 2 Thus it seems imperative that we devise strategies that can help us in identifying these patients quite early in their clinical course, so that we can implement measures to improve the outcome of such patients.
One of the major determinants of postoperative outcome is the cardiorespiratory function of the patient. It has been demonstrated that global tissue hypoxia is associated with poor results after major surgeries. 3, 4 This can be reduced by optimal volume replacement and inotropes. 5, 6 Despite this, it is important that we recognize the symptoms of tissue hypoxia in advance, so that we may be well equipped to handle the situation. Mixed venous oxygen saturation (SvO 2 ) and central venous oxygen saturation (ScvO 2 ) have been found to be surrogate markers of tissue hypoxia. 7, 8 Clinicians must be aware of the measurement, advantages, and pitfalls of the above markers, so that they can be applied safely and effectively. The aim of this article is to describe the physiology of SvO 2 and ScvO 2 , elucidate the findings of pertinent clinical investigations, and debate on the equality or interchangeability of SvO 2 and ScvO 2 . We searched PubMed, Google Scholar, and Cochrane databases with the following keywords: venous saturation, venous oximetry, tissue hypoxia, and cardiac surgery.
Background Physiology
It is mandatory we understand the physiology of venous saturation before we apply it in the bedside management of the patient. What do SvO 2 and ScvO 2 represent? They represent the hemoglobin saturation of the blood in the pulmonary artery and superior vena cava, respectively. What are the factors influencing the saturation of the venous blood? The oxygen saturation of the venous blood is dependent on the hemoglobin levels (Hb), arterial oxygen saturation (SaO 2 ), cardiac output (CO), and tissue oxygen consumption (VO 2 ). Therefore, as per the Fick principle, 9 SvO 2 is described by the following formula:
The normal range of venous saturation is usually 65 to 75% in healthy individuals; however, few studies exist, which showcase the normal values. 10 The earliest study, which provided an in-depth description of Hb saturation in the venous system of healthy patients, demonstrated mean values of 76.8% in the superior vena cava and 78.4% in the pulmonary arteries. It is usually recommended to target an ScvO 2 > 70% and an SvO 2 > 65% in all subset of patients. It is also recommended to follow a trend in the values rather than initiating therapy based on a single value.
How do we measure venous oxygen saturation? Although the measurement of ScvO 2 and SvO 2 was initiated in the catheterization laboratory in 1929, it was the landmark paper by Swann et al, 11 which described the floatation of the pulmonary artery catheter that facilitated the routine measurement of SvO 2 . Nowadays, estimation of saturation can be done either intermittently by blood sampling or continuously through the use of a spectrophotometric catheter. 12, 13 A host of physiologic, pathologic, and therapeutic factors influence the venous saturation during the perioperative period (►Table 1). Recognizing the etiology is necessary for the safe use of venous saturation as a therapeutic goal.
Central versus Mixed Venous Oxygen Saturation
The interchangeability or equality of ScvO 2 and SvO 2 has been a matter of great debate over many years in pediatric and adult population [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] (►Table 2). In clinical practice, the simplicity of ScvO 2 measurement has always been a factor for clinicians to equate the two variables. The determinants of both the variables are nearly similar. Despite this, it has to be understood that they cannot always be used interchangeably. This becomes more valid in case of critically ill patients. The differences in the blood flow distribution and oxygen consumption by the vital organs such as the brain and heart in shock states explains this discrepancy. 25 Normally, the difference between ScvO 2 and SvO 2 is around 5%, with the ScvO 2 lagging behind SvO 2 . This is due to the relatively higher VO 2 of the brain and the higher oxygen content of the inferior vena cava. 26 However, in shock states the redistribution of blood to the upper extremities leads to a reversal in the relationship. Hence, in critically ill patients, the ScvO 2 overtakes SvO 2 by 15 to 20%. 27 Therefore, measuring the ScvO 2 in such cases may provide us a false sense of security that everything is quite rosy. This may also be expanded to the perioperative period although with mixed results. The general consensus during surgery is that while the two may a have a good positive correlation, they agree with each other only when measured as a trend and not as absolute values. 28 To conclude, clinicians must be very prudent in surmising the value of one variable from the other. 
Conclusion
The debate as to whether ScvO 2 and SvO 2 are interchangeable is never ending. Although it has generally been agreed that in critically ill patients they must be assessed individually, the same may or may not be applicable to a patient undergoing surgery. We must focus on well-defined population and use these variables with knowledge and discretion. In clinical practice, venous oxygen saturations should always be used in combination with vital signs and other relevant endpoints to tailor therapy. Finally, it needs not be stressed that a trend in the saturation monitoring is always preferred to a solitary value. 
